Levodopa versus non-levodopa brain language fMRI in Parkinson's disease.

Autor: Arantes PR; Instituto do Cérebro, Hospital Israelita Albert Einstein., Gobato HH, Davoglio BB, Barreiros MÂ, Felício AC, Barsottini OG, Andrade LA, Amaro Junior E
Jazyk: English; Portuguese
Zdroj: Einstein (Sao Paulo, Brazil) [Einstein (Sao Paulo)] 2012 Apr-Jun; Vol. 10 (2), pp. 171-9.
DOI: 10.1590/s1679-45082012000200010
Abstrakt: Objective: To identify the effect of levodopa in language areas in Parkinson's disease patients.
Methods: We evaluated 50 patients with mild to moderate Parkinson's disease, age and gender paired to 47 healthy volunteers. We selected two homogeneous groups of 18 patients taking levodopa and 7 no levodopa patients. The functional magnetic resonance imaging verbal fluency task, with low and high cognitive demands, was performed at a 3T magnetic resonance imaging equipment. Data was analyzed with XBAM software for group maps and ANOVA comparison.
Results: Patients without levodopa had more activation than the ones with levodopa in the medial frontal and in the left frontal and parieto-occipital areas. The striatal activation in patients taking levodopa had similar result of the activation detected in the healthy volunteer group. Parieto-occipital areas were less activated in the levodopa group than in the no levodopa one.
Conclusion: Parkinson's disease patients without levodopa replacement, during a verbal fluency effort, had more diffuse and intense cerebral activation in left hemisphere, mainly in the frontal and parieto-occipital areas. The striatal activation in verbal fluency of patients with levodopa intake was more similar to the activation found in healthy volunteers. These initial evidences suggested a role of levodopa inhibiting activation in parieto-occipital compensating areas.
Databáze: MEDLINE